Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
VHH-His tag NanoAb™ Targeting Human CD30, clone 9063
VHH-His tag NanoAb™ Targeting Human CD30, clone 9063 (FITC)
VHH-His tag NanoAb™ Targeting Human CD33, clone D064
VHH-His tag NanoAb™ Targeting Human CD63, clone 3033
VHH-His tag NanoAb™ Targeting Human CD7, clone 6131
VHH-His tag NanoAb™ Targeting Human CGRP, clone E070
VHH-His tag NanoAb™ Targeting Human CGRP, clone E070 (FITC)
VHH-His tag NanoAb™ Targeting Human Clostridium difficile enterotoxin B, clone L068
VHH-His tag NanoAb™ Targeting Human Clostridium difficile enterotoxin B, clone L068 (FITC)
VHH-His tag NanoAb™ Targeting Human DR5, clone 1100
VHH-His tag NanoAb™ Targeting Human DR5, clone 1100 (FITC)
VHH-His tag NanoAb™ Targeting Human EGFR, clone 1019